ORA vs VRTX · P/E 61, $7.75B cap vs P/E 30, rev $12.00B
Ormat Technologies Inc (ORA) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Ormat Technologies Inc (ORA) is a utilities - renewable company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
ORA does not have a complete income-statement cache yet.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ORA currently screens at market cap $7.75B and trailing P/E 60.6. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ORA and VRTX stock pages for the full models.
Not investment advice.